Hestetun, Kjersti Elvestad <br/><br/>
Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  Apr 2015 
 - 470-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.3109/0284186X.2014.952386  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Aged<br/>Antimetabolites, Antineoplastic<br/>Biomarkers, Tumor--metabolism<br/>Cell Nucleus--metabolism<br/>Chemotherapy, Adjuvant<br/>Colonic Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Levamisole--therapeutic use<br/>Male<br/>Middle Aged<br/>Rectal Neoplasms--drug therapy<br/>Retrospective Studies<br/>Serpins--metabolism<br/>Tissue Array Analysis